Awiqli® FlexTouch Pen for Diabetes in Adults

This weekly insulin pen contains insulin icodec, a long-acting basal insulin for diabetes. This guide supports ordering with US delivery from Canada and explains key safety points. It also outlines how to check savings without insurance and what supplies are needed.

What Awiqli Is and How It Works

YouDrugstore is a licensed Canadian pharmacy in Manitoba. Pharmacists review prescriptions before dispensing..

Awiqli® is a basal insulin, meaning background insulin that controls glucose between meals and overnight. Insulin icodec is designed to last longer in the body, so it is taken less often than daily basal insulins. This medicine lowers blood glucose by helping sugar move from the bloodstream into body tissues.

Because it is an insulin, it does not replace healthy eating or activity plans. It is also not used to treat diabetic ketoacidosis. A prescriber may use it alone or with other diabetes medicines.

Who It’s For

This treatment is indicated to help improve glycemic control in adults with diabetes mellitus. It may be used in type 2 diabetes and, when needed, alongside mealtime insulin for type 1 diabetes. Background information on common care plans is also covered in Type 2 Diabetes resources.

People who need a less frequent basal schedule may be considered candidates. A clinician will decide if weekly basal insulin fits current therapy and glucose patterns. For a review of how oral therapy can fit in type 2 care, see Role In Type 2 Diabetes.

Avoid use in anyone with a known serious allergy to insulin icodec or any ingredient. Extra caution is often needed in people with frequent low glucose episodes, those who cannot monitor glucose reliably, and people with acute illness. Pregnancy and breastfeeding decisions should follow the official product information and clinician guidance.

Dosage and Usage

This insulin is given as a subcutaneous injection, meaning it is injected under the skin. It is intended for once-weekly dosing, taken on the same day each week. A prescriber selects the starting dose based on prior insulin use and overall diabetes therapy.

Do not mix this insulin with other insulins in the same syringe. Do not inject into a vein or muscle unless the label specifically allows it. Typical injection areas include the abdomen, thigh, or upper arm, and sites are rotated to reduce skin thickening.

For general pen technique reminders, the Pen Tips And Instructions article can help with step-by-step handling concepts. Always follow the device instructions that come with the pen because steps can differ by model. Use glucose monitoring as directed by the prescriber, especially after therapy changes.

Strengths and Forms

Awiqli FlexTouch prefilled pen is supplied as a disposable, multi-dose injection pen. This weekly basal insulin is commonly listed as 700 units/mL, but availability may vary by market. Some pharmacies may stock different pack sizes or presentations depending on supplier.

Confirm the exact presentation on the carton and the pharmacy label. A clinician or pharmacist can also confirm what is being dispensed. Keep the package insert for device-specific details.

Missed Dose and Timing

Weekly dosing works best when taken consistently on the scheduled day. If a dose is missed, the product information may allow taking it within a set window, depending on when the next dose is due. When the timing is unclear, follow the official label and contact the prescriber.

Avoid taking two doses too close together unless the label specifically instructs it. If a dose is taken on a different day, the weekly schedule may need to be reset based on the prescribing instructions. Glucose checks can help identify whether extra monitoring is needed after a missed dose.

Storage and Travel Basics

Store unopened pens in a refrigerator when possible, commonly at 2°C to 8°C. Do not freeze, and do not use a pen that has been frozen. Protect the pen from direct light and excessive heat.

Once in use, many insulin pens can be kept at room temperature for a limited time, but limits vary by product. Check the carton and the package insert for in-use storage conditions and the discard date after first use. Keep the cap on when not in use.

For travel, keep insulin with carry-on items and avoid checked baggage temperature extremes. Bring more supplies than expected and pack a spare needle set. If glucose monitoring supplies are needed, the Glucose Test Strips page can help with compatible options.

Pen Handling and Sharps Disposal

Use a new needle for each injection and never share pens. Follow the instructions for attaching the needle, priming, dialing, and injecting. This helps reduce blocked needles and dosing errors.

Awiqli FlexTouch Pen injector steps can vary by device version and market. The key steps usually include priming, injecting under the skin, holding the button down, and counting for several seconds before removing the needle. After use, remove the needle and place it into an approved sharps container.

• Prime the pen: clears air and checks flow.
• Rotate injection sites: lowers risk of lumps.
• Use a sharps container: reduces needle-stick injuries.
• Replace the cap: protects from light and damage.

Local rules for sharps disposal differ by area. Many pharmacies or community programs accept filled sharps containers. Keep sharps away from children and pets at all times.

Benefits

This medicine provides basal insulin coverage with fewer scheduled injections than daily basal options. It can be used as part of a broader diabetes plan that may include oral agents or mealtime insulin. The pen format can also simplify handling compared with vial-and-syringe routines.

• Weekly schedule: fewer planned basal injections.
• Basal coverage: supports fasting glucose control.
• Pen dosing: built for repeat use.
• Flexible regimens: may pair with other therapies.

Side Effects and Safety

Common effects may occur with any insulin therapy. Many are related to low blood glucose or injection technique. Some effects improve as routines become consistent.

• Low blood sugar: can cause sweating or shakiness.
• Injection-site reactions: redness, pain, or swelling.
• Weight gain: can occur with insulin use.
• Edema: swelling in hands or feet.
• Skin changes: lumps from repeated site use.

Serious risks can include severe hypoglycaemia, allergic reactions, or very low potassium (hypokalaemia). Risk of hypoglycaemia increases when insulin is used with sulfonylureas or with mealtime insulin. Seek urgent care for symptoms of a severe allergic reaction, such as facial swelling or trouble breathing.

Drug Interactions and Cautions

Many medicines can affect glucose control, so medication lists should be reviewed at each refill. Some drugs raise glucose, including corticosteroids and some diuretics. Others can increase hypoglycaemia risk, including other glucose-lowering therapies.

Beta blockers may mask warning signs of low glucose, such as tremor or fast heartbeat. Alcohol can also increase hypoglycaemia risk in some people. Any insulin adjustment should be guided by the prescriber rather than done independently.

What to Expect Over Time

Basal insulin changes often require more glucose checks at first, especially around fasting readings. Dose adjustments are typically gradual and based on patterns, not single readings. Logging results can support safer titration discussions.

Some people notice early changes in fasting glucose, while others need several dosing cycles and adjustments. Illness, travel, and changes in meals can shift insulin needs, even on a stable regimen. Consistent injection timing and site rotation help reduce day-to-day variability.

Compare With Alternatives

Other basal insulin pens may be prescribed when a daily schedule is preferred or when a weekly option is not suitable. Options stocked by YouDrugstore can include Toujeo® SoloStar Pens and Basaglar® KwikPen. Another alternative some clinicians use is insulin detemir in cartridge form, depending on availability and local guidance.

Comparisons should focus on dosing frequency, glucose targets, device preferences, and safety history. A pharmacist can help confirm whether an alternative is therapeutically similar, but the final decision rests with the prescriber. Do not switch between basal products without clinical direction.

Pricing and Access

Awiqli FlexTouch Pen price can vary by strength, package size, and supplier availability. Many people compare cash-pay options when coverage is limited or plans require a high deductible. At checkout, pricing is shown clearly before payment.

YouDrugstore supports Canadian pricing with US shipping from Canada for eligible orders. Prescription required and verified. For coupon-style offers that may apply to select items, visit Promotions for current details.

Diabetes medicines often come with ongoing supply needs. The Diabetes Care category can help bundle supplies in one cart. If help is needed, pharmacy staff can explain what documentation is required.

Availability and Substitutions

Stock can change due to manufacturer supply or regional distribution limits. If the specific presentation is unavailable, a prescriber may recommend another basal insulin or a different device format. Substitution decisions depend on the prescribed product, local rules, and clinical needs.

Pharmacists can contact prescribers when a change is needed, but therapy changes are not automatic. Keep the original prescription information available to reduce delays. If an alternative is selected, confirm training needs for the new device.

Patient Suitability and Cost-Saving Tips

Awiqli FlexTouch Pen refill planning matters because basal insulin is a maintenance medicine. Setting calendar reminders can help keep weekly dosing on track and prevent gaps. Multi-month dispensing may be possible depending on the prescription and insurer rules.

To reduce waste, track pen start dates and storage conditions. Keep a spare needle supply and a backup glucose testing plan, especially when traveling. If other diabetes medicines are also taken, review the full regimen at each renewal to avoid overlaps.

• Refill early: allows time for verification steps.
• Bundle supplies: reduce separate orders and gaps.
• Track pen dates: avoid using expired in-use pens.
• Store correctly: protect insulin from heat.

Questions to Ask Your Clinician

• Weekly schedule: which day should be used?
• Starting dose: how is it chosen from current therapy?
• Hypoglycaemia plan: what are warning signs and steps?
• Monitoring: how often to check fasting glucose?
• Other medicines: any changes needed with sulfonylureas?
• Sick-day rules: how to handle illness and reduced intake?

Authoritative Sources

For official prescribing details, consult these references. Read the European assessment summary on the European Medicines Agency website. Review Canadian drug listings using the Health Canada Drug Product Database. For US label lookups, search records in DailyMed By The U.S. National Library.

Place your order using prompt, express, cold-chain shipping options at checkout.

This content is for informational purposes only and is not a substitute for professional medical advice.